Search research articles
Contact Us
Filters
Showing results (381-390 of 461) with videos related to
Page
of 47
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 21, 2004
Phase II study of ISIS 3521, an antisense oligodeoxynucleotide to protein kinase C alpha, in patients with previously treated low-grade non-Hodgkin's lymphoma
S Rao, D Watkins, D Cunningham, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 27, 2025
Tremor and disability outcomes following deep brain stimulation for multiple sclerosis-associated tremor
Samantha A Banks, Matthew R Baker, Eoin P Flanagan, et al.
Nature Communications
|
February 27, 2024
TopBP1 utilises a bipartite GINS binding mode to support genome replication
Matthew Day, Bilal Tetik, Milena Parlak, et al.
Msystems
|
August 15, 2019
Engineered Interspecies Amino Acid Cross-Feeding Increases Population Evenness in a Synthetic Bacterial Consortium
Marika Ziesack, Travis Gibson, John K W Oliver, et al.
Journal of the Neurological Sciences
|
July 23, 2013
Frequent inaccuracies in ABCD2 scoring in non-stroke specialists' referrals to a daily Rapid Access Stroke Prevention service
David Bradley, Simon Cronin, Justin A Kinsella, et al.
Journal of Neurology
|
October 21, 2025
Cervical cord atrophy correlates with intracranial lesion burden in tumefactive multiple sclerosis
Albert Aboseif, Caitlin S Jackson-Tarlton, Christopher G Schwarz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
July 28, 2025
Percutaneous epidural spinal cord stimulation immediately reduces clonus in an individual with multiple sclerosis
Anders J Asp, Omid Jahanian, Megan L Gill, et al.
Radiology
|
March 9, 2021
Generative Adversarial Networks to Synthesize Missing T1 and FLAIR MRI Sequences for Use in a Multisequence Brain Tumor Segmentation Model
Gian Marco Conte, Alexander D Weston, David C Vogelsang, et al.
Cancer
|
October 19, 2022
Cabozantinib for previously treated radioiodine-refractory differentiated thyroid cancer: Updated results from the phase 3 COSMIC-311 trial
Marcia S Brose, Bruce G Robinson, Steven I Sherman, et al.
The Lancet. Oncology
|
July 8, 2021
Cabozantinib for radioiodine-refractory differentiated thyroid cancer (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3 trial
Marcia S Brose, Bruce Robinson, Steven I Sherman, et al.
Page
of 47
Search research articles
Search
Showing results (381-390 of 461) with videos related to
Sort By:
Page
of 47
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 21, 2004
Phase II study of ISIS 3521, an antisense oligodeoxynucleotide to protein kinase C alpha, in patients with previously treated low-grade non-Hodgkin's lymphoma
S Rao, D Watkins, D Cunningham, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 27, 2025
Tremor and disability outcomes following deep brain stimulation for multiple sclerosis-associated tremor
Samantha A Banks, Matthew R Baker, Eoin P Flanagan, et al.
Nature Communications
|
February 27, 2024
TopBP1 utilises a bipartite GINS binding mode to support genome replication
Matthew Day, Bilal Tetik, Milena Parlak, et al.
Msystems
|
August 15, 2019
Engineered Interspecies Amino Acid Cross-Feeding Increases Population Evenness in a Synthetic Bacterial Consortium
Marika Ziesack, Travis Gibson, John K W Oliver, et al.
Journal of the Neurological Sciences
|
July 23, 2013
Frequent inaccuracies in ABCD2 scoring in non-stroke specialists' referrals to a daily Rapid Access Stroke Prevention service
David Bradley, Simon Cronin, Justin A Kinsella, et al.
Journal of Neurology
|
October 21, 2025
Cervical cord atrophy correlates with intracranial lesion burden in tumefactive multiple sclerosis
Albert Aboseif, Caitlin S Jackson-Tarlton, Christopher G Schwarz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
July 28, 2025
Percutaneous epidural spinal cord stimulation immediately reduces clonus in an individual with multiple sclerosis
Anders J Asp, Omid Jahanian, Megan L Gill, et al.
Radiology
|
March 9, 2021
Generative Adversarial Networks to Synthesize Missing T1 and FLAIR MRI Sequences for Use in a Multisequence Brain Tumor Segmentation Model
Gian Marco Conte, Alexander D Weston, David C Vogelsang, et al.
Cancer
|
October 19, 2022
Cabozantinib for previously treated radioiodine-refractory differentiated thyroid cancer: Updated results from the phase 3 COSMIC-311 trial
Marcia S Brose, Bruce G Robinson, Steven I Sherman, et al.
The Lancet. Oncology
|
July 8, 2021
Cabozantinib for radioiodine-refractory differentiated thyroid cancer (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3 trial
Marcia S Brose, Bruce Robinson, Steven I Sherman, et al.
Page
of 47